Regulated Information - Global

Filter

Period

Filter by

Reset

Showing: 1 – 05 of 152 Regulated Information

Show

Sort

Combined Shareholders’ Meeting of 24 May 2022

Press Release Icon

– 24 May 2022

24 May 2022

Combined Shareholders’ Meeting of 24 May 2022

Ipsen delivers a strong sales performance in the first quarter of 2022

Press Release Icon

– 27 April 2022

27 April 2022

Download

Ipsen delivers a strong sales performance in the first quarter of 2022

Q1 2022 – Sales presentation (1,014.94 KB)

Webcast Q1 2022

Ipsen presents strong full-year 2021 results and enters into exclusive negotiations to divest its Consumer Healthcare business

Press Release Icon

– 11 February 2022

11 February 2022

Download

Ipsen presents strong full-year 2021 results and enters into exclusive negotiations to divest its Consumer Healthcare business

Attachment

FY 2021 – Results presentation (2.17 MB)

Webcast replay FY 2021

Ipsen and GENFIT enter into exclusive licensing agreement for elafibranor, a Phase III asset evaluated in Primary Biliary Cholangitis, as part of a long-term global partnership

Press Release Icon

– 17 December 2021

17 December 2021

Download

Ipsen and GENFIT enter into exclusive licensing agreement for elafibranor, a Phase III asset evaluated in Primary Biliary Cholangitis, as part of a long-term global partnership

Ipsen delivers strong sales growth for the first nine months and improves its full-year guidance

Press Release Icon

– 21 October 2021

21 October 2021

Download

Ipsen delivers strong sales growth for the first nine months and improves its full-year guidance

YTD 2021 – Sales presentation (851.58 KB)

1 … 24 25 26 27 28 29 30 31